Grown Rogue International (GRUSF) Cost of Revenue (2011 - 2026)

Grown Rogue International's (GRUSF) quarterly Cost of Revenue came in at $5.2 million in Q1 2026, up 37.28% year-on-year from $3.8 million in Q1 2025, and up 100.0% quarter-over-quarter from -$8358.1 billion in Q4 2025.

Grown Rogue International (GRUSF) Cost of Revenue (2011 - 2026) Analysis & Trends

Grown Rogue International's Cost of Revenue history runs 13 years deep, the most recent figure standing at $5.2 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 37.28% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was -$2301491018.4 billion, a 13346765336231.92% decrease from a year earlier, with the FY2025 full-year figure at $18.3 million, up 36.64% from the prior year.
  • Cost of Revenue advanced to $5.2 million in Q1 2026 per GRUSF's latest filing, from -$8358.1 billion in the prior quarter.
  • Across five years, Cost of Revenue topped out at $1780.1 billion in Q3 2025 and bottomed at -$2301484440.5 billion in Q2 2025.
  • The 5-year median for Cost of Revenue is $224636.0 (2023), against an average of -$153432734.6 billion.
  • Biggest YoY gain for Cost of Revenue was 5170235979.08% in 2025; the steepest drop was 5278709936550273.0% in 2025.
  • Year by year, Cost of Revenue stood at $1.4 million in 2022, then tumbled by 93.72% to $89210.0 in 2023, then soared by 14897.59% to $13.4 million in 2024, then slumped by 62469968.47% to -$8358.1 billion in 2025, then jumped by 100.0% to $5.2 million in 2026.
  • Per Business Quant, the three latest GRUSF Cost of Revenue figures stand at $5.2 million (Q1 2026), -$8358.1 billion (Q4 2025), and $1780.1 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 2.01 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 641.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 2.59 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 133.40 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 2.36 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 13.80 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 586.00 Mn
10 Grown Rogue International 99.97 Mn 86.26 Mn 3.96 Mn 5.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.20 Mn
Mar 31, 2026 5.20 Mn
Dec 31, 2025 -8,358.06 Bn
Dec 31, 2025 -8,358.06 Bn
Sep 30, 2025 1,780.12 Bn
Sep 30, 2025 1,780.12 Bn
Jun 30, 2025 -2,301,484,440.47 Bn
Jun 30, 2025 -2,301,484,440.47 Bn
Mar 31, 2025 3.79 Mn
Mar 31, 2025 3.79 Mn
Dec 31, 2024 13.38 Mn
Dec 31, 2024 13.38 Mn
Sep 30, 2024 34,430.05
Sep 30, 2024 34,430.05
Jun 30, 2024 43,599.37
Jun 30, 2024 43,599.37
Mar 31, 2024 100,069.00
Mar 31, 2024 100,069.00
Dec 31, 2023 89,210.00
Dec 31, 2023 89,210.00